Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Argan (AGX) over the last 17 years, with Q4 2025 value amounting to -$7.5 million.

  • Argan's Cash from Financing Activities fell 852.44% to -$7.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$40.9 million, marking a year-over-year decrease of 5965.18%. This contributed to the annual value of -$26.1 million for FY2025, which is 3.84% down from last year.
  • Argan's Cash from Financing Activities amounted to -$7.5 million in Q4 2025, which was down 852.44% from -$6.9 million recorded in Q3 2025.
  • Over the past 5 years, Argan's Cash from Financing Activities peaked at -$2.9 million during Q2 2021, and registered a low of -$30.7 million during Q2 2022.
  • Moreover, its 5-year median value for Cash from Financing Activities was -$7.2 million (2024), whereas its average is -$11.1 million.
  • In the last 5 years, Argan's Cash from Financing Activities plummeted by 95251.8% in 2022 and then surged by 7972.34% in 2023.
  • Quarter analysis of 5 years shows Argan's Cash from Financing Activities stood at -$3.6 million in 2021, then tumbled by 277.17% to -$13.5 million in 2022, then surged by 58.78% to -$5.6 million in 2023, then fell by 24.78% to -$6.9 million in 2024, then fell by 8.52% to -$7.5 million in 2025.
  • Its Cash from Financing Activities stands at -$7.5 million for Q4 2025, versus -$6.9 million for Q3 2025 and -$18.0 million for Q2 2025.